Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL862543 | 0.74 | IDO1 (0.31) | — | |
| SCHEMBL862319 | 0.72 | IDO1 (0.30) | — | |
| SCHEMBL26326828 | 0.67 | — | — | |
| SCHEMBL12667569 | 0.65 | IDO1 (0.31) | — | |
| SCHEMBL16621762 | 0.65 | — | — | |
| SCHEMBL77010 | 0.64 | IDO1 (0.35) | — | |
| SCHEMBL17807589 | 0.64 | MC4R (0.36) | KDM4E | |
| SCHEMBL16621758 | 0.64 | DYRK1A (0.38) | — | |
| SCHEMBL862412 | 0.62 | — | — | |
| Hydrochloric Acid SCHEMBL27173500 | 0.62 | KDM4E (0.31) | KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180094290-A1 | Cationic Polymer Based Wired Enzyme Formulations for Use in Analyte Sensors | ABBOTT DIABETES CARE INC. (US) | 2018-04-05 | — | — | US | disclosed |
| US-9885073-B2 | Cationic polymer based wired enzyme formulations for use in analyte sensors | ABBOTT DIABETES CARE INC. (US) | 2018-02-06 | — | — | US | disclosed |
| US-20170051329-A1 | Cationic Polymer Based Wired Enzyme Formulations for Use in Analyte Sensors | ABBOTT DIABETES CARE INC. | 2017-02-23 | — | — | US | disclosed |
| US-20160296147-A1 | Redox Polymers | THERASENSE, INC. | 2016-10-13 | — | — | US | disclosed |
| US-9428785-B2 | Cationic polymer based wired enzyme formulations for use in analyte sensors | ABBOTT DIABETES CARE INC. (US) | 2016-08-30 | — | — | US | disclosed |
| US-9320467-B2 | Redox polymers | ABBOTT DIABETES CARE INC. (US) | 2016-04-26 | — | — | US | disclosed |
| US-20150090590-A1 | Cationic Polymer Based Wired Enzyme Formulations for Use in Analyte Sensors | ABBOTT DIABETES CARE INC. | 2015-04-02 | — | — | US | disclosed |
| US-20140364710-A1 | Redox Polymers | THERASENSE, INC. | 2014-12-11 | — | — | US | disclosed |
| US-8906211-B2 | Cationic polymer based wired enzyme formulations for use in analyte sensors | ABBOTT DIABETES CARE INC. (US) | 2014-12-09 | — | — | US | disclosed |
| US-8828204-B2 | Redox polymers | ABBOTT DIABETES CARE INC. (US) | 2014-09-09 | — | — | US | disclosed |
| US-20130034664-A1 | Biosensor Coating Composition and Methods Thereof | ABBOTT DIABETES CARE INC. | 2013-02-07 | — | — | US | disclosed |
| US-8226814-B2 | Transition metal complexes with pyridyl-imidazole ligands | ABBOTT DIABETES CARE INC. (US) | 2012-07-24 | — | — | US | disclosed |
| US-20120138484-A1 | Analyte Sensors Comprising Thickeners, Enzyme Stabilizers and Osmium Boronates | ABBOTT DIABETES CARE INC. | 2012-06-07 | — | — | US | disclosed |
| US-20120132525-A1 | REDOX POLYMERS FOR USE IN ANALYTE MONITORING | ABBOTT DIABETES CARE INC. | 2012-05-31 | — | — | US | disclosed |
| US-8168052-B2 | Transition metal complexes with bidentate ligand having an imidazole ring | ABBOTT DIABETES CARE INC. (US) | 2012-05-01 | — | — | US | disclosed |
| US-20110303537-A1 | Redox Polymers | ABBOTT DIABETES CARE INC. | 2011-12-15 | — | — | US | disclosed |
| US-20110303538-A1 | Redox Polymers | ABBOTT DIABETES CARE INC. | 2011-12-15 | — | — | US | disclosed |
| US-20110306111-A1 | Redox Polymers | ABBOTT DIABETES CARE INC. | 2011-12-15 | — | — | US | disclosed |
| US-8070934-B2 | For use as redox mediators in enzyme-based electrochemical sensors; electrolytic cells; glucose sensors for diabetes monitoring; kits | ABBOTT DIABETES CARE INC. (US) | 2011-12-06 | — | — | US | disclosed |
| US-7918976-B2 | Transition metal complexes with bidentate ligand having an imidazole ring | ABBOTT DIABETES CARE INC. (US) | 2011-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170051329-A1 | Cationic Polymer Based Wired Enzyme Formulations for Use in Analyte Sensors | PEPD, MGAM, NAAA | KDM4E 1719/4885 |
| US-20180094290-A1 | Cationic Polymer Based Wired Enzyme Formulations for Use in Analyte Sensors | PEPD, MGAM, NAAA | KDM4E 1719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.